<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/abel/Downloads/grobid-0.5.6/grobid-home/schemas/xsd/Grobid.xsd" xml:space="preserve">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">WHO: COVID-19 virus LABORATORY TEST REQUEST FORM 1</title>
			</titleStmt>
			<publicationStmt>
				<publisher />
				<availability status="unknown"><licence /></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Karen</forename><surname>Nahapetyan</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Francis</forename><surname>Inbanathan</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Dmitriy</forename><surname>Pereyaslov</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christine</forename><surname>Uhlenhaut</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Varja</forename><surname>Grabovac</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Katelijn</forename><surname>Vandemaele</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Magdi</forename><surname>Samaan</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christian</forename><surname>Fuster</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wenqing</forename><surname>Zhang</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lisa</forename><surname>Stevens</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Chris</forename><surname>Oxenford</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sebastian</forename><surname>Cognat</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kazunobu</forename><surname>Kojima</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Carmen</forename><surname>Dolea</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Caroline</forename><surname>Brown</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">C&#233;line</forename><surname>Barnadas</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maria</forename><forename type="middle">Van</forename><surname>Kerkhove</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lisa</forename><surname>Carter</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mark</forename><forename type="middle">D</forename><surname>Perkins</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Karin</forename><surname>Von Eije</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Annex I</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">WHO: COVID-19 virus LABORATORY TEST REQUEST FORM 1</title>
					</analytic>
					<monogr>
						<imprint>
							<date />
						</imprint>
					</monogr>
				</biblStruct>
			</sourceDesc>
		</fileDesc>

		<encodingDesc>
			<appInfo>
				<application ident="GROBID" version="0.5.6" when="2020-03-16T22:29+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>		<profileDesc>
			<abstract />
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div><head n="1.">Introduction</head><p>Several coronaviruses can infect humans, the globally endemic human coronaviruses HCoV-229E, HCoV-NL63, HCoV-HKU1 and HCoV-OC43 that tend to cause mild respiratory disease, and the zoonotic Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV) that have a higher case fatality rate. In December 2019, a cluster of patients with a novel coronavirus was identified in Wuhan, China </p><p>The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in COVID-19 virus laboratory testing of patients.</p><p>Existing WHO documents have been consulted for drafting this interim guidance, including the interim guidance on laboratory testing for MERS </p></div>
<div><head n="2.">Laboratory testing guiding principles for patients who meet the suspect case definition</head><p>The decision to test should be based on clinical and epidemiological factors and linked to an assessment of the likelihood of infection. PCR testing of asymptomatic or mildly symptomatic contacts can be considered in the assessment of individuals who have had contact with a COVID-19 case. Screening protocols should be adapted to the local situation. The case definitions are being regularly reviewed and updated as new information becomes available. For the WHO suspect case definition see: Global Surveillance for human infection with coronavirus disease (COVID-2019) </p><p>Rapid collection and testing of appropriate specimens from patients meeting the suspect case definition for COVID-19 is a priority for clinical management and outbreak control and should be guided by a laboratory expert. Suspect cases should be screened for the virus with nucleic acid amplification tests (NAAT), such as RT-PCR.</p><p>If testing for COVID- </p><p>If case management requires, patients should be tested for other respiratory pathogens using routine laboratory procedures, as recommended in local management guidelines for community-acquired pneumonia. Additional testing should not delay testing for COVID-19. As co-infections can occur, all patients that meet the suspect case definition should be tested for COVID-19 virus regardless of whether another respiratory pathogen is found.</p><p>Laboratory testing for coronavirus disease 2019  in suspected human cases.</p></div>
<div><head>Interim guidance 2 March 2020</head><p>In an early study in Wuhan, the mean incubation period for COVID-19 was 5.2 days among 425 cases, though it varies widely between individuals </p></div>
<div><head n="3.">Specimen collection and shipment</head><p>Safety procedures during specimen collection Ensure that adequate SOPs are in use and that staff are trained for appropriate specimen collection, storage, packaging and transport. All specimens collected for laboratory investigations should be regarded as potentially infectious.</p><p>Ensure that health care workers who collect specimens adhere rigorously to infection prevention and control guidelines. Specific WHO interim guidance has been published: "Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected, interim guidance, January 2020" </p></div>
<div><head>Specimens to be collected</head><p>At minimum, respiratory material should be collected:</p><p>upper respiratory specimens: nasopharyngeal and oropharyngeal swab or wash in ambulatory patients and/or lower respiratory specimens: sputum (if produced) and/or endotracheal aspirate or bronchoalveolar lavage in patients with more severe respiratory disease. (Note high risk of aerosolization; adhere strictly to infection prevention and control procedures).</p><p>Additional clinical specimens may be collected as COVID-19 virus has been detected in blood and stool, as had the coronaviruses responsible for SARS and MERS </p><p>Further recommendations on materials to collect, including the testing of asymptomatic individuals, can be found in </p></div>
<div><head>Packaging and shipment of clinical specimens</head><p>Specimens for virus detection should reach the laboratory as soon as possible after collection. Correct handling of specimens during transportation is essential. Specimens which can be delivered promptly to the laboratory can be stored and shipped at 2-8&#176;C. When there is likely to be a delay in specimens reaching the laboratory, the use of viral transport medium is strongly recommended. Specimens may be frozen to -20&#176;C or ideally -70&#176;C and shipped on dry ice if further delays are expected (see </p><p>Transport of specimens within national borders should comply with applicable national regulations. International transport of potentially COVID-19 virus containing samples should follow the UN Model Regulations, and any other applicable regulations depending on the mode of transport being used. More information may be found in the "WHO Guidance on regulations for the Transport of</p></div>
<div><head>Box 1. Biosafety practices in the laboratory</head><p>Testing on clinical specimens from patients meeting the suspect case definition should be performed in appropriately equipped laboratories by staff trained in the relevant technical and safety procedures. National guidelines on laboratory biosafety should be followed in all circumstances. There is still limited information on the risk posed by COVID-19, but all procedures should be undertaken based on a risk assessment. Specimen handling for molecular testing would require BSL-2 or equivalent facilities. Attempts to culture the virus require BSL-3 facilities at minimum.</p><p>For more information related to COVID-19 risk assessment, see specific interim guidance document: 'WHO interim guidance for laboratory biosafety related to 2019-nCoV' </p><p>Infectious Substances 2019-2020" </p></div>
<div><head>Ensure good communication with the laboratory and provide needed information</head><p>Alerting the laboratory before sending specimens encourages proper and timely processing of samples and timely reporting. Specimens should be correctly labelled and accompanied by a diagnostic request form (template provided in Annex I). When there are discordant results, the patient should be resampled and, if appropriate, sequencing of the virus from the original specimen or of an amplicon generated from an appropriate NAAT assay, different from the NAAT assay initially used, should be obtained to provide a reliable test result.</p></div>
<div><head n="4.">Laboratory testing for COVID-19 virus</head><p>Laboratories are urged to seek confirmation of any surprising results in an international reference laboratory.</p></div>
<div><head>Laboratory confirmed case by NAAT in areas with established COVID-19 virus circulation</head><p>In areas where COVID-19 virus is widely spread a simpler algorithm might be adopted in which for example screening by rRT-PCR of a single discriminatory target is considered sufficient.</p></div>
<div><head>One or more negative results do not rule out the possibility of COVID-19 virus infection. A number of factors could lead to a negative result in an infected individual, including:</head><p>poor quality of the specimen, containing little patient material (as a control, consider determining whether there is adequate human DNA in the sample by including a human target in the PCR testing) -the specimen was collected late or very early in the infection the specimen was not handled and shipped appropriately technical reasons inherent in the test, e.g. virus mutation or PCR inhibition.</p><p>If a negative result is obtained from a patient with a high index of suspicion for COVID-19 virus infection, particularly when only upper respiratory tract specimens were collected, additional specimens, including from the lower respiratory tract if possible, should be collected and tested.</p><p>Each NAAT run should include both external and internal controls, and laboratories are encouraged to participate in external quality assessment schemes when they become available. It is also recommended to laboratories who order their own primers and probes to perform entry testing/validation on functionality and potential contaminants. </p></div>
<div><head>Viral sequencing</head><p>In addition to providing confirmation of the presence of the virus, regular sequencing of a percentage of specimens from clinical cases can be useful to monitor for viral genome mutations that might affect the performance of medical countermeasures, including diagnostic tests. Virus whole genome sequencing can also inform molecular epidemiology studies. Many publicaccess databases for deposition of genetic sequence data are available, including GISAID, which is intended to protect the rights of the submitting party (27).</p></div>
<div><head>Viral culture</head><p>Virus isolation is not recommended as a routine diagnostic procedure.</p></div>
<div><head n="6.">Reporting of cases and test results</head><p>Laboratories should follow national reporting requirements. In general, all test results, positive or negative, should be immediately reported to national authorities. States Parties to the IHR are reminded of their obligations to share with WHO relevant public health information for events for which they notified WHO, using the decision instrument in Annex 1 of the IHR (2005) (28).</p></div>
<div><head n="7.">Research toward improved detection of COVID-19 virus</head><p>Many aspects of the virus and disease are still not understood. A better understanding will be needed to provide improved guidance. For example:  Baseline serum taken as early as possible within incubation period of contact and convalescent serum taken 2-4 weeks after last contact (optimal timing for convalescent sample needs to be established). Aside from specific collection materials indicated in the table also assure other materials and equipment are available: e.g. transport containers and specimen collection bags and packaging, coolers and cold packs or dry ice, sterile blood-drawing equipment (e.g. needles, syringes and tubes), labels and permanent markers, PPE, materials for decontamination of surfaces etc. </p></div><note place="foot">Laboratory testing for coronavirus disease 2019 in suspected human cases</note>
		<figDesc>Specimens to be collected from symptomatic patients and contactsWithin incubation period of last documented contact.</figDesc><figDesc>Specimen collection and storage (adapted from ref 6 and ref 29,30) &#176;C if &#8804; 5 days -70 &#176;C (dry ice) if &gt; 5 days * For transport of samples for viral detection, use viral transport medium (VTM) containing antifungal and antibiotic supplements. Avoid repeated freezing and thawing of specimens. If VTM is not available sterile saline may be used in place of VTM (in such case, duration of sample storage at 2-8 &#176;C may be different from what is indicated above).</figDesc><figDesc>Shu-Yuan Xiao, Yingjie Wu, Juan Li, Evolving status of the 2019 novel coronavirus infections: proposal of conventional serologic assays for disease diagnostics and infection monitoring. 2020, J Med Virol. 2020;1-4. 27) GISAID.org (https://www.gisaid.org/), accessed on 19 February 2020 28) World Health Organization. International Health Regulations (2005), third edition. Geneva: World Health Organization; 2016 (http://www.who.int/ihr/publications/97892 41580496/en/). 29) Protocol to investigate non-seasonal influenza and other emerging acute respiratory diseases. Geneva: World Health Organization; 2018. (https://www.who.int/influenza/resources/p ublications/outbreak_investigation_protoco l/en/). 30) Bruce et al. JCM. 2011. Evaluation of Swabs, Transport Media, and Specimen Transport Conditions for Optimal Detection of Viruses by PCR.</figDesc></body>
		<back>

			<div type="acknowledgement">
<div />
			</div>

			<div type="annex">
<div><p>All specimens collected should be regarded as potentially infectious and you must contact the reference laboratory before sending samples. &#169; World Health Organization 2020. All rights reserved. This is a draft. The content of this document is not final, and the text may be subject to revisions before publication. The document may not be reviewed, abstracted, quoted, reproduced, transmitted, distributed, translated or adapted, in part or in whole, in any form or by any means without the permission of the World Health Organization. </p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">A novel coronavirus from patients with pneumonia in China</title>
		<author>
			<persName><forename type="first">Na</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dingyu</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wenling</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Xingwang</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bo</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jingdong</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Xiang</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Baoying</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Weifeng</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Roujian</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Peihua</forename><surname>Niu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Faxian</forename><surname>Zhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Xuejun</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dayan</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wenbo</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Guizhen</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">George</forename><forename type="middle">F</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wenjie</forename><surname>Tan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<date type="published" when="2019" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main">Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group</title>
		<imprint />
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Severe acute respiratory syndrome-related coronavirus: The species and its viruses -a statement of the Coronavirus Study Group</title>
		<author>
			<persName><forename type="first">Alexander</forename><forename type="middle">E</forename><surname>Gorbalenya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Susan</forename><forename type="middle">C</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ralph</forename><forename type="middle">S</forename><surname>Baric</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Raoul</forename><forename type="middle">J</forename><surname>De Groot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Christian</forename><surname>Drosten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Anastasia</forename><forename type="middle">A</forename><surname>Gulyaeva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bart</forename><forename type="middle">L</forename><surname>Haagmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chris</forename><surname>Lauber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andrey</forename><forename type="middle">M</forename><surname>Leontovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Benjamin</forename><forename type="middle">W</forename><surname>Neuman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dmitry</forename><surname>Penzar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Stanley</forename><surname>Perlman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Leo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dmitry</forename><surname>Poon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Igor</forename><forename type="middle">A</forename><surname>Samborskiy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Isabel</forename><surname>Sidorov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">John</forename><surname>Sola</surname></persName>
		</author>
		<author>
			<persName><surname>Ziebuhr</surname></persName>
		</author>
		<idno type="DOI">10.1101/2020.02.07.937862</idno>
		<idno>2020.02.07.937862</idno>
		<ptr target="https://doi.org/10.1101/2020.02.07.937862" />
		<imprint />
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Laboratory testing for Middle East Respiratory Syndrome coronavirus, interim guidance (revised)</title>
		<ptr target="https://apps.who.int/iris/bitstream/handle/1" />
	</analytic>
	<monogr>
		<title level="j">World Health Organization</title>
		<imprint>
			<date type="published" when="2018" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title level="m" type="main">0665/259952/WHO-MERS-LAB-15.1-Rev1-2018-eng.pdf;jsessionid=08939A780A5A4552E C8279D0E6D650E4?sequence=1)</title>
		<imprint />
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title level="m" type="main">Managing epidemics, key facts about major deadly diseases. Geneva: World Health Organization</title>
		<ptr target="https://apps.who.int/iris/handle/10665/272442" />
		<imprint>
			<date type="published" when="2018" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">WHO Global Influenza Surveillance Network Manual for the laboratory diagnosis and virological surveillance of influenza</title>
		<ptr target="https://www.who.int/influenza/gisrs_laboratory/manual_diagnosis_surveillance_influenza/en/" />
	</analytic>
	<monogr>
		<title level="j">WHO</title>
		<imprint>
			<date type="published" when="2011" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title level="m" type="main">Protocol to investigate non-seasonal influenza and other emerging acute respiratory diseases. Geneva: World Health Organization</title>
		<ptr target="https://www.who.int/influenza/resources/publications/outbreak_investigation_protocol/en/" />
		<imprint>
			<date type="published" when="2018" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<monogr>
		<title level="m" type="main">Guideline for the collection of clinical specimens during field investigation of outbreaks WHO</title>
		<idno>CSR/EDC/200.4</idno>
		<ptr target="https://www.who.int/ihr/publications/WHO_CDS_CSR_EDC_2000_4/en/" />
		<imprint />
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Geneva: World Health Organization</title>
		<ptr target="http://www.who.int/csr/resources/publications/biosafety/WHO_CDS_CSR_LYO_2004_11/en/" />
	</analytic>
	<monogr>
		<title level="m">WHO laboratory biosafety manual</title>
		<imprint>
			<date type="published" when="2004" />
		</imprint>
	</monogr>
	<note>third edition</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Interim guidance, Geneva, World Health Organization</title>
		<ptr target="https://www.who.int/publications-detail/global-surveillance-for-human-infection-with-novel-coronavirus-(2019-ncov" />
	</analytic>
	<monogr>
		<title level="m">Global Surveillance for human infection with coronavirus disease (COVID-2019)</title>
		<imprint>
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main">Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia</title>
		<author>
			<persName><forename type="first">Qun</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Xuhua</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Peng</forename><surname>Wu</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2020-01-29" />
		</imprint>
		<respStmt>
			<orgName>N Eng Jour Med</orgName>
		</respStmt>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
				<author>
			<persName><forename type="first">Zheng-Yi</forename><surname>Wei-Jie Guan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yu</forename><surname>Ni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wen-Hua</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chun-Quan</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jian-Xing</forename><surname>Ou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lei</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Hong</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chun-Liang</forename><surname>Shan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">David</forename><forename type="middle">S C</forename><surname>Lei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bin</forename><surname>Hui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Lan-Juan</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Guang</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Kwok-Yung</forename><surname>Zeng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ru-Chong</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chunli</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Tao</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ping-Yan</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jie</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><surname>Xiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jin-Lin</forename><surname>Shi-Yue Li 1</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Zi-Jing</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yi-Xiang</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Li</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yong</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ya-Hua</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Peng</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jian-Ming</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ji-Yang</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Zhong</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gang</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><surname>Zhi-Jian</surname></persName>
		</author>
		<author>
			<persName><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jie</forename><surname>Shao-Qin Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chang-Jiang</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Nan-Shan</forename><surname>Shao-Yong Zhu</surname></persName>
		</author>
		<author>
			<persName><surname>Zhong</surname></persName>
		</author>
		<idno type="DOI">10.1101/2020.02.06.20020974</idno>
		<ptr target="https://doi.org/10.1101/2020.02.06.20020974" />
		<title level="m">Clinical characteristics of 2019 novel coronavirus infection in China. medRxiv preprint doi</title>
		<imprint />
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title level="m" type="main">Hiroshi Nishiura. Incubation Period and Other Epidemiological Characteristics</title>
		<author>
			<persName><forename type="first">Tetsuro</forename><surname>Nathalie M Linton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yichi</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Katsuma</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Andrei</forename><forename type="middle">R</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sung-Mok</forename><surname>Akhmetzhanov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Baoyin</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ryo</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><surname>Kinoshita</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2019" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data</title>
	</analytic>
	<monogr>
		<title level="j">J. Clin. Med</title>
		<imprint>
			<biblScope unit="volume">2020</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">538</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title />
		<idno type="DOI">10.3390/jcm9020538</idno>
		<ptr target="https://doi.org/10.3390/jcm9020538" />
		<imprint />
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title level="m" type="main">Management of Corona Virus Disease-19 (COVID-19): the Zhejiang Experience</title>
		<author>
			<persName><surname>Xu Kaijin</surname></persName>
		</author>
		<author>
			<persName><surname>Hongliu</surname></persName>
		</author>
		<author>
			<persName><surname>Shen Yihong</surname></persName>
		</author>
		<idno type="DOI">Univ.DOI&#65306;10.3785/j.issn.1008-9292.2020.02.02</idno>
		<imprint />
	</monogr>
	<note type="report_type">Jour Zhejiang</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes</title>
		<author>
			<persName><forename type="first">Wei</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Rong-Hui</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bei</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Xiao-Shuang</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Xing-Lou</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ben</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yan-Yi</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Geng-Fu</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Bing</forename><surname>Yan</surname></persName>
		</author>
		<idno type="DOI">10.1080/22221751.2020.1729071</idno>
		<ptr target="https://www.tandfonline.com/doi/full/10.1080/22221751.2020.1729071" />
	</analytic>
	<monogr>
		<title level="j">Emerging Microbes &amp; Infections</title>
		<editor>Zheng-Li Shi &amp; Peng Zhou</editor>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope from="386" to="389" unit="page" />
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Isolation of 2019-nCoV from a Stool Specimen of a Laboratory-Confirmed Case of the Coronavirus Disease</title>
		<author>
			<persName><forename type="first">Yong</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Cao</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Shuangli</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Chang</forename><surname>Shu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dongyan</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jingdong</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yang</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wei</forename><surname>Zhen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Zijian</forename><surname>Feng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Guizhen</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jun</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wenbo</forename><surname>Xu</surname></persName>
		</author>
		<idno>COVID-19</idno>
	</analytic>
	<monogr>
		<title level="j">CCDC Weekly</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">8</biblScope>
			<date type="published" when="2019" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<title level="m" type="main">Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected, interim guidance</title>
		<ptr target="https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125" />
		<imprint>
			<date type="published" when="2020-01" />
		</imprint>
	</monogr>
	<note>Geneva: World Health Organization</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">World Health Organization</title>
		<ptr target="https://www.who.int/docs/default-source/coronaviruse/laboratory-biosafety-novel-coronavirus-version-1-1.pdf?sfvrsn=912a9847_2" />
	</analytic>
	<monogr>
		<title level="m">Laboratory biosafety guidance related to the novel coronavirus (2019-nCoV)</title>
		<imprint>
			<biblScope unit="volume">2020</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Severe acute respiratory syndrome associated coronavirus is detected in intestinal tissues of fatal cases</title>
		<author>
			<persName><forename type="first">X</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Gong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Gao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Gastroenterol</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope from="169" to="176" unit="page" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Adv</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">11</biblScope>
			<date type="published" when="2017" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J, Pathol</title>
		<imprint>
			<biblScope unit="volume">203</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope from="622" to="630" unit="page" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">World Health Organization</title>
		<ptr target="https://www.who.int/ihr/publications/WHO-WHE-CPI-2019.20/en/" />
	</analytic>
	<monogr>
		<title level="m">Guidance on regulations for the transport of infectious substances 2019-2020</title>
		<meeting><address><addrLine>Geneva</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2019" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<monogr>
		<title level="m" type="main">Guidance to minimize risks for facilities collecting, handling or storing materials potentially infectious for polioviruses (PIM Guidance). Geneva: World Health Organization</title>
		<ptr target="http://polioeradication.org/wp-content/uploads/2016/07/PIM-guidance-20190122-EN.pdf" />
		<imprint>
			<date type="published" when="2018" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Serological assays for emerging coronaviruses: challenges and pitfalls</title>
		<author>
			<persName><forename type="first">B</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Drosten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>M&#252;ller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virus Res</title>
		<imprint>
			<biblScope unit="volume">194</biblScope>
			<biblScope from="175" to="83" unit="page" />
			<date type="published" when="2014-12-19" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Analysis of the first family epidemic situation of new coronavirus pneumonia in Gansu Province</title>
		<author>
			<persName><forename type="first">Bai</forename><surname>Shaoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Wang</forename><surname>Jianyun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">(</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yu</forename><surname>Yingquan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gao</forename><surname>Desheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Li</forename><surname>Xiaomin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yang</forename><surname>Lingling</surname></persName>
		</author>
		<author>
			<persName><surname>Fan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chinese Journal of Preventive medicine</title>
		<imprint>
			<biblScope unit="page">54</biblScope>
			<date type="published" when="2020" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>